Search
Wednesday 14 October 2015
  • :
  • :

NASDAQ Stocks News Buzz: C.H. Robinson Worldwide, (NASDAQ:CHRW), BreitBurn Energy Partners L.P. (NASDAQ:BBEP), Arch Capital Group (NASDAQ:ACGL), Pernix Therapeutics Holdings (NASDAQ:PTX)

On Wednesday, C.H. Robinson Worldwide, Inc.(NASDAQ:CHRW)’s shares declined -0.19% to $62.27.

C.H. Robinson Worldwide, Inc. (CHRW) will hold its quarterly conference call to talk about second quarter 2015 results on Wednesday, July 29, 2015, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). The results will be released via press release after market close on Tuesday, July 28, 2015. We invite call participants to submit questions in advance of the conference call and we will respond to as many of the questions as we can in the time allowed. To submit your question(s) in advance of the call, please email [email protected].

C.H. Robinson Worldwide, Inc., a third party logistics company, provides freight transportation services and logistics solutions to companies in various industries worldwide. It offers transportation and logistics services, such as truckload comprising time-definite and expedited truck transportation services; less than truckload services; intermodal transportation, which is shipment service of freight in trailers or containers by combination of truck and rail; and non-vessel ocean common carrier or freight forwarding services, in addition to organizes air shipments and provides door-to-door services.

BreitBurn Energy Partners L.P.(NASDAQ:BBEP)’s shares dropped -4.41% to $4.55.

Breitburn Energy Partners LP (BBEP) declared a cash distribution of $0.04166 per common unit for the first month attributable to the second quarter of 2015, payable on July 17, 2015, to record holders of its common units at the close of business on July 14, 2015. This monthly distribution is equal to a distribution of $0.50 per common unit on an annualized basis.

Breitburn also declared recently distributions for its 8.25% Series A Cumulative Redeemable Perpetual Preferred Units (BBEPP) and 8.0% Series B Perpetual Convertible Preferred Units. A cash distribution of $0.171875 per Series A Unit is payable on August 17, 2015, to record holders of its Series A Units at the close of business on July 31, 2015. This monthly distribution is equal to an annual distribution of $2.0625 per Series A Unit. Breitburn has elected to pay the distribution on the Series B Units in kind by issuing additional Series B Units instead of paying a cash distribution. A distribution of 0.006666 PIK unit per Series B Unit is payable on July 15, 2015, to record holders of Series B Units at the close of business on June 30, 2015.

Breitburn Energy Partners LP, an independent oil and gas partnership, acquires, exploits, and develops oil, natural gas liquids (NGLs), and natural gas properties in the United States. The company’s oil, NGL, and natural gas reserves are primarily located in seven producing areas comprising the Arkansas, Louisiana, and East Texas; Michigan, Indiana, and Kentucky; Permian Basin in Texas and New Mexico; the Mid-Continent covering Oklahoma, Kansas, and the Texas Panhandle; Rockies in Wyoming; Florida and Alabama; and California.

At the end of Wednesday’s trade, Arch Capital Group Ltd. (NASDAQ:ACGL)‘s shares surged 2.46% to $68.61.

Arch Capital Group Ltd. [ACGL] declared that it anticipates to release its 2015 second quarter results after the close of regular stock market hours on Wednesday, July 29, 2015. The Company will hold a conference call for investors and analysts at 11:00 a.m. Eastern Time on Thursday, July 30, 2015.

Arch Capital Group Ltd., through its auxiliaries, provides property, casualty, and mortgage insurance and reinsurance products worldwide. Its Insurance segment offers primary and excess casualty coverages; loss sensitive primary casualty insurance programs; collateral protection, debt cancellation, and service contract reimbursement products; directors’ and officers’ liability, errors and omissions liability, employment practices and fiduciary liability, crime, professional indemnity, and other financial related coverages; and medical professional and general liability insurance coverages. This segment also provides commercial automobile and inland marine; property, energy, marine, and aviation insurance; travel insurance; accident, disability, and medical plan insurance coverages; captive insurance programs; excess workers’ compensation and employers’ liability insurance coverages; and contract and commercial surety coverages.

Pernix Therapeutics Holdings Inc (NASDAQ:PTX), ended its Wednesday’s trading session with -2.20% loss, and closed at $5.79.

Bellamy Young, actress and singer, best known for her role as First Lady ‘Mellie’ Grant on ABC’s drama “Scandal”, has partnered with Pernix Therapeutics (PTX), the makers of TREXIMET®, to share her experience with migraines in conjunction with National Migraine Awareness Month. As one of the more than 36 million Americans1 who suffer from migraines, Bellamy hopes to drive national awareness of the impact migraines can have, particularly in the summer when warmer weather and shifts in daily routines may trigger symptoms.

As Bellamy is well aware, the unpredictable, intense pain of migraines often impacts sufferers’ personal and professional lives in a meaningful way. In fact, a new survey conducted by Everyday Health, Inc., on behalf of Pernix Therapeutics revealed that 8 in 10 female migraine sufferers2 said having migraines makes them feel less in control of their lives, while half agreed their personal relationships suffer because of their migraines.

Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells branded and generic pharmaceutical products. The company’s product comprise CEDAX, an oral cephalosporin used for the treatment of mild to moderate acute bacterial exacerbations of chronic bronchitis, middle ear infection due to haemophilus influenza, or streptococcus pyogene; Zutripro, Rezira, and Vituz for the relief of cough and nasal congestion; and OMECLAMOX-PAK a gastroenterology product.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *